However, in the large tumour size (≥6 cm) group, low-undifferentiated group and TNM advanced stage group (III-IV), GC patients with INPP4B+ seemed to have a shorter OS than patients with INPP4B- (Figure 2E, 2F, 2G, respectively). This evidence concerns the gene INPP4B and neoplasm.